907
Views
4
CrossRef citations to date
0
Altmetric
Research Paper

Clinical characteristics and risk factors associated with breakthrough varicella during varicella outbreaks

ORCID Icon, , , , , & show all
Pages 1851-1856 | Received 30 Sep 2019, Accepted 09 Dec 2019, Published online: 02 Mar 2020

References

  • Heininger U, Seward JF. Varicella. Lancet. 2006;368:1365–76.
  • Wutzler P, Bonanni P, Burgess M, Gershon A, Sáfadi MA, Casabona G. Varicella vaccination - the global experience. Expert Rev Vaccines. 2017;16:833–43.
  • Marin M, Marti M, Kambhampati A, Jeram SM, Seward JF. Global varicella vaccine effectiveness: a meta-analysis. Pediatrics. 2016;137:e20153741.
  • Marin M, Zhang JX, Seward JF. Near elimination of varicella deaths in the US after implementation of the vaccination program. Pediatrics. 2011;128:214–20.
  • Quinn HE, Gidding HF, Marshall HS, Booy R, Elliott EJ, Richmond P, Crawford N, McIntyre PB, Macartney KK. PAEDS (Paediatric Active Enhanced Disease Surveillance) network. Varicella vaccine effectiveness over 10 years in Australia; moderate protection from 1-dose program. J Infect. 2019;78:220–25.
  • Spackova M, Muehlen M, Siedler A. Complications of varicella after implementation of routine childhood varicella vaccination in Germany. Pediatr Infect Dis J. 2010;29:884–86.
  • Nguyen HQ, Jumaan AO, Seward JF. Decline in mortality due to varicella after implementation of varicella vaccination in the United States. N Engl J Med. 2005;352:450–58.
  • Suo L, Lu L, Wang Q, Yang F, Wang X, Pang X, Marin M, Wang C. Varicella outbreak in a highly-vaccinated school population in Beijing, China during the voluntary two-dose era. Vaccine. 2017;35:4368–73.
  • Macartney K. Prevention of varicella: time for two-dose vaccination. Lancet. 2014;383:1276–77.
  • Gould PL, Leung J, Scott C, Schmid DS, Deng H, Lopez A, Chaves SS, Reynolds M, Gladden L, Harpaz R, et al. An outbreak of varicella in elementary school children with two-dose varicella vaccine recipients–Arkansas, 2006. Pediatr Infect Dis J. 2009;28(8):678–81.
  • Galil K, Lee B, Strine T, Carraher C, Baughman AL, Eaton M, Montero J, Seward J. Outbreak of varicella at a day-care center despite vaccination. N Engl J Med. 2002;347:1909–15.
  • Guris D, Jumaan AO, Mascola L, Watson BM, Zhang JX, Chaves SS, Gargiullo P, Perella D, Civen R, Seward JF. Changing varicella epidemiology in active surveillance sites–United States, 1995-2005. J Infect Dis. 2008;197:S71–75.
  • Zhu YF, Li YF, Du Y, Zeng M. Epidemiological characteristics of breakthrough varicella infection during varicella outbreaks in Shanghai, 2008-2014. Epidemiol Infect. 2017;145:2129–36.
  • Bernstein HH, Rothstein EP, Watson BM, Reisinger KS, Blatter MM, Wellman CO, Chartrand SA, Cho I, Ngai A, White CJ. Clinical survey of natural varicella compared with breakthrough varicella after immunization with live attenuated Oka/Merck varicella vaccine. Pediatrics. 1993;92:833–37.
  • Seward JF, Zhang JX, Maupin TJ, Mascola L, Jumaan AO. Contagiousness of varicella in vaccinated cases: a household contact study. JAMA. 2004;292:704–08.
  • Unim B, Saulle R, Boccalini S, Taddei C, Ceccherini V, Boccia A, Bonanni P, La Torre G. Economic evaluation of VAricella vaccination: results of a systematic review. Hum Vaccin Immunother. 2013;9:1932–42.
  • Zhang X, Yan Y, Liu F, Luo Y, Zhang J, Peng X, Zhang Y, Han S, Zhao J, He Y. The epidemiology and risk factors for breakthrough varicella in Beijing Fengtai district. Vaccine. 2012;30:6186–89.
  • Zhu S, Zeng F, Xia L, He H, Zhang J. Incidence rate of breakthrough varicella observed in healthy children after 1 or 2 doses of varicella vaccine: results from a meta-analysis. Am J Infect Control. 2018;46:e1–1e7.
  • Pan X, Shu M, Ma R, Fang T, Dong H, Sun Y, Xu G. Varicella breakthrough infection and effectiveness of 2-dose varicella vaccine in China. Vaccine. 2018;36:5665–70.
  • Chaves SS, Gargiullo P, Zhang JX, Civen R, Guris D, Mascola L, Seward JF. Loss of vaccine-induced immunity to varicella over time. N Engl J Med. 2007;356:1121–29.
  • Tugwell BD, Lee LE, Gillette H, Lorber EM, Hedberg K, Cieslak PR. Chickenpox outbreak in a highly vaccinated school population. Pediatrics. 2004;113:455–59.
  • Galil K, Fair E, Mountcastle N, Britz P, Seward J. Younger age at vaccination may increase risk of varicella vaccine failure. J Infect Dis. 2002;186:102–05.
  • Lim YJ, Chew FT, Tan AY, Lee BW. Risk factors for breakthrough varicella in healthy children. Arch Dis Child. 1998;79:478–80.
  • Umaretiya PJ, Swanson JB, Kwon HJ, Grose C, Lohse CM, Juhn YJ. Asthma and risk of breakthrough varicella infection in children. Allergy Asthma Proc. 2016;37:207–15.
  • Black S, Ray P, Shinefield H, Saddier P, Nikas A. Lack of association between age at varicella vaccination and risk of breakthrough varicella, within the Northern California kaiser permanente medical care program. J Infect Dis. 2008;197:S139–42.
  • Fu J, Wang J, Jiang C, Shi R, Ma T. Outbreak of varicella in a highly vaccinated preschool population. Int J Infect Dis. 2015;3714–18.
  • Verstraeten T, Jumaan AO, Mullooly JP, Seward JF, Izurieta HS, DeStefano F, Black SB, Chen RT. Vaccine safety datalink research group. A retrospective cohort study of the association of varicella vaccine failure with asthma, steroid use, age at vaccination, and measles-mumps-rubella vaccination. Pediatrics. 2003;112:e98–103.
  • Baxter R, Ray P, Tran TN, Black S, Shinefield HR, Coplan PM, Lewis E, Fireman B, Saddier P. Long-term effectiveness of varicella vaccine: a 14-Year, prospective cohort study. Pediatrics. 2013;131:e1389–96.
  • Zhang X, Yu Y, Zhang J, Kwan EP, Huang S, Wang Z, Zhang J, Peng X, Yan Y, Zhang L, et al. One-dose vaccination associated with attenuated disease severity of adolescent and adult varicella cases in Beijing’s Fengtai District. Hum Vaccin Immunother. 2014;10(8):2417–20.
  • Spackova M, Wiese-Posselt M, Dehnert M, Matysiak-Klose D, Heininger U, Siedler A. Comparative varicella vaccine effectiveness during outbreaks in day-care centres. Vaccine. 2010;28:686–91.
  • Varicella and herpes zoster vaccines: WHO position paper, June 2014. Wkly Epidemiol Rec. 2014;89(25):265–87.
  • Holl K, Sauboin C, Amodio E, Bonanni P, Gabutti G. Coverage, efficacy or dosing interval: which factor predominantly influences the impact of routine childhood vaccination for the prevention of varicella? A model-based study for Italy. BMC Public Health. 2016;16:1103.
  • Lopez AS, LaClair B, Buttery V, Zhang Y, Rosen J, Taggert E, Robinson S, Davis M, Waters C, Thomas CA, et al. Varicella outbreak surveillance in schools in sentinel jurisdictions, 2012-2015. J Pediatric Infect Dis Soc. 2019;8(2):122–27.
  • Liu AP, Sun TT. Meta-analysis of varicella vaccine coverage among Chinese children. Chin J Vaccin Immunization. 2017;23(6):698–704. In Chinese
  • Sui HT, Li JC, Wang M, Liu YM, Yin DP. Varicella epidemiology in China,2005-2015. Chin J Vaccin Immunization. 2019;25(2):155–59. In Chinese
  • Marin M, Meissner HC, Seward JF. Varicella prevention in the United States: a review of successes and challenges. Pediatrics. 2008;122:e744–51.
  • Streng A, Grote V, Carr D, Hagemann C, Liese JG. Varicella routine vaccination and the effects on varicella epidemiology - results from the Bavarian Varicella Surveillance Project (BaVariPro), 2006-2011. BMC Infect Dis. 2013;13303.
  • Chaves SS, Zhang J, Civen R, Watson BM, Carbajal T, Perella D, Seward JF. Varicella disease among vaccinated persons: clinical and epidemiological characteristics, 1997-2005. J Infect Dis. 2008;197:S127–31.
  • Suo L, Lu L, Chen M, Pang X. Antibody induced by one-dose varicella vaccine soon became weak in children: evidence from a cross-sectional seroepidemiological survey in Beijing, PRC. BMC Infect Dis. 2015;15509.
  • Wang Z, Yang H, Li K, Zhang A, Feng Z, Seward JF, Bialek SR, Wang C. Single-dose varicella vaccine effectiveness in school settings in China. Vaccine. 2013;31:3834–38.
  • Bonanni P, Gershon A, Gershon M, Kulcsár A, Papaevangelou V, Rentier B, Sadzot-Delvaux C, Usonis V, Vesikari T, Weil-Olivier C, et al. Primary versus secondary failure after varicella vaccination: implications for interval between 2 doses. Pediatr Infect Dis J. 2013;32(7):e305–13.
  • Cao Z, Chen D, Yang Y, Zhang D. Effectiveness of post-exposure prophylaxis during varicella outbreaks among primary and middle school students in Shanghai: an analysis of three-year surveillance data. Vaccine. 2018;36:5754–59.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.